HIV and cervical cancer in Kenya
- PMID: 11818095
- DOI: 10.1016/s0020-7292(01)00560-4
HIV and cervical cancer in Kenya
Abstract
Objectives: To determine the effect of the HIV epidemic on invasive cervical cancer in Kenya.
Methods: Of the 3902 women who were diagnosed with reproductive tract malignancies at Kenyatta National Hospital (KNH) from 1989 to 1998, 85% had invasive cervical cancer. Age at presentation and severity of cervical cancer were studied for a 9-year period when national HIV prevalence went from 5% to 5-10%, to 10-15%.
Results: There was no significant change in either age at presentation or severity of cervical cancer. Of the 118 (5%) women who were tested for HIV, 36 (31%) were seropositive. These women were 5 years younger at presentation than HIV-negative women.
Conclusions: A two- to three-fold increase in HIV prevalence in Kenya did not seem to have a proportional effect on the incidence of cervical cancer. Yet, HIV-positive women who presented with cervical cancer were significantly younger than HIV-negative women.
Similar articles
-
Epidemiology of Cervical Squamous Intraepithelial Lesions in HIV Infected Women in Kenya: a cross-Sectional Study.Afr J Reprod Health. 2015 Mar;19(1):133-9. Afr J Reprod Health. 2015. PMID: 26103703
-
Changes in cervical cancer incidence after three decades of screening US women less than 30 years old.Obstet Gynecol. 2003 Oct;102(4):765-73. doi: 10.1016/s0029-7844(03)00696-3. Obstet Gynecol. 2003. PMID: 14551007
-
Invasive cervical cancer and human immunodeficiency virus (HIV) infection: a South African perspective.Int J Gynecol Cancer. 2001 May-Jun;11(3):194-7. doi: 10.1046/j.1525-1438.2001.01022.x. Int J Gynecol Cancer. 2001. PMID: 11437924
-
Cervical cancer: prevention and treatment.Discov Med. 2012 Aug;14(75):125-31. Discov Med. 2012. PMID: 22935209 Review.
-
Squamous cell cervical lesions in women with and without AIDS. Biochemical risk factors, prevention, and policy.Cancer Nurs. 1994 Aug;17(4):294-307. Cancer Nurs. 1994. PMID: 7954377 Review.
Cited by
-
Cervical cancer screening prevalence and its correlates in Cameroon: secondary data analysis of the 2018 demographic and health surveys.BMC Public Health. 2021 Jun 5;21(1):1071. doi: 10.1186/s12889-021-11024-z. BMC Public Health. 2021. PMID: 34090372 Free PMC article.
-
Barriers to Cervical Cancer Screening in Rural Kenya: Perspectives from a Provider Survey.J Community Health. 2015 Aug;40(4):756-61. doi: 10.1007/s10900-015-9996-1. J Community Health. 2015. PMID: 25677728 Free PMC article.
-
Influence of HIV/AIDS on Cervical Cancer: A Retrospective Study From Tanzania.J Glob Oncol. 2016 Jun 1;3(1):72-78. doi: 10.1200/JGO.2015.002964. eCollection 2017 Feb. J Glob Oncol. 2016. PMID: 28717744 Free PMC article.
-
Long-term incidence of cervical cancer in women with human immunodeficiency virus.Cancer. 2009 Feb 1;115(3):524-30. doi: 10.1002/cncr.24067. Cancer. 2009. PMID: 19127538 Free PMC article.
-
Prevalence, characteristics, and outcomes of HIV-positive women diagnosed with invasive cancer of the cervix in Kenya.Int J Gynaecol Obstet. 2013 Dec;123(3):231-5. doi: 10.1016/j.ijgo.2013.07.010. Epub 2013 Sep 10. Int J Gynaecol Obstet. 2013. PMID: 24095308 Free PMC article.